secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001213900-25-038442
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial Pharmaceuticals replaces auditor Marcum with CBIZ CPAs effective April 28, 2025
--------------------------------------------------------------------------------

- Marcum resigned as independent auditor; CBIZ CPAs engaged for FY 2025, effective immediately.
- Marcum's reports for FY 2024 and 2023 included a going-concern explanatory paragraph but no adverse opinion.
- No disagreements with Marcum; previously reported material weaknesses in internal controls continue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025038442/0001213900-25-038442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025038442/ea0240327-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-038442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer